Cargando…
The non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetes
Model organisms are becoming increasingly important for the study of complex diseases such as type 1 diabetes (T1D). The non-obese diabetic (NOD) mouse is an experimental model for T1D having been bred to develop the disease spontaneously in a process that is similar to humans. Genetic analysis of t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668384/ https://www.ncbi.nlm.nih.gov/pubmed/23729657 http://dx.doi.org/10.1093/database/bat032 |
_version_ | 1782271623539195904 |
---|---|
author | Steward, Charles A. Gonzalez, Jose M. Trevanion, Steve Sheppard, Dan Kerry, Giselle Gilbert, James G. R. Wicker, Linda S. Rogers, Jane Harrow, Jennifer L. |
author_facet | Steward, Charles A. Gonzalez, Jose M. Trevanion, Steve Sheppard, Dan Kerry, Giselle Gilbert, James G. R. Wicker, Linda S. Rogers, Jane Harrow, Jennifer L. |
author_sort | Steward, Charles A. |
collection | PubMed |
description | Model organisms are becoming increasingly important for the study of complex diseases such as type 1 diabetes (T1D). The non-obese diabetic (NOD) mouse is an experimental model for T1D having been bred to develop the disease spontaneously in a process that is similar to humans. Genetic analysis of the NOD mouse has identified around 50 disease loci, which have the nomenclature Idd for insulin-dependent diabetes, distributed across at least 11 different chromosomes. In total, 21 Idd regions across 6 chromosomes, that are major contributors to T1D susceptibility or resistance, were selected for finished sequencing and annotation at the Wellcome Trust Sanger Institute. Here we describe the generation of 40.4 mega base-pairs of finished sequence from 289 bacterial artificial chromosomes for the NOD mouse. Manual annotation has identified 738 genes in the diabetes sensitive NOD mouse and 765 genes in homologous regions of the diabetes resistant C57BL/6J reference mouse across 19 candidate Idd regions. This has allowed us to call variation consequences between homologous exonic sequences for all annotated regions in the two mouse strains. We demonstrate the importance of this resource further by illustrating the technical difficulties that regions of inter-strain structural variation between the NOD mouse and the C57BL/6J reference mouse can cause for current next generation sequencing and assembly techniques. Furthermore, we have established that the variation rate in the Idd regions is 2.3 times higher than the mean found for the whole genome assembly for the NOD/ShiLtJ genome, which we suggest reflects the fact that positive selection for functional variation in immune genes is beneficial in regard to host defence. In summary, we provide an important resource, which aids the analysis of potential causative genes involved in T1D susceptibility. Database URLs: http://www.sanger.ac.uk/resources/mouse/nod/; http://vega-previous.sanger.ac.uk/info/data/mouse_regions.html |
format | Online Article Text |
id | pubmed-3668384 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-36683842013-05-31 The non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetes Steward, Charles A. Gonzalez, Jose M. Trevanion, Steve Sheppard, Dan Kerry, Giselle Gilbert, James G. R. Wicker, Linda S. Rogers, Jane Harrow, Jennifer L. Database (Oxford) Original Article Model organisms are becoming increasingly important for the study of complex diseases such as type 1 diabetes (T1D). The non-obese diabetic (NOD) mouse is an experimental model for T1D having been bred to develop the disease spontaneously in a process that is similar to humans. Genetic analysis of the NOD mouse has identified around 50 disease loci, which have the nomenclature Idd for insulin-dependent diabetes, distributed across at least 11 different chromosomes. In total, 21 Idd regions across 6 chromosomes, that are major contributors to T1D susceptibility or resistance, were selected for finished sequencing and annotation at the Wellcome Trust Sanger Institute. Here we describe the generation of 40.4 mega base-pairs of finished sequence from 289 bacterial artificial chromosomes for the NOD mouse. Manual annotation has identified 738 genes in the diabetes sensitive NOD mouse and 765 genes in homologous regions of the diabetes resistant C57BL/6J reference mouse across 19 candidate Idd regions. This has allowed us to call variation consequences between homologous exonic sequences for all annotated regions in the two mouse strains. We demonstrate the importance of this resource further by illustrating the technical difficulties that regions of inter-strain structural variation between the NOD mouse and the C57BL/6J reference mouse can cause for current next generation sequencing and assembly techniques. Furthermore, we have established that the variation rate in the Idd regions is 2.3 times higher than the mean found for the whole genome assembly for the NOD/ShiLtJ genome, which we suggest reflects the fact that positive selection for functional variation in immune genes is beneficial in regard to host defence. In summary, we provide an important resource, which aids the analysis of potential causative genes involved in T1D susceptibility. Database URLs: http://www.sanger.ac.uk/resources/mouse/nod/; http://vega-previous.sanger.ac.uk/info/data/mouse_regions.html Oxford University Press 2013-05-31 /pmc/articles/PMC3668384/ /pubmed/23729657 http://dx.doi.org/10.1093/database/bat032 Text en © The Author(s) 2013. Published by Oxford University Press. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Steward, Charles A. Gonzalez, Jose M. Trevanion, Steve Sheppard, Dan Kerry, Giselle Gilbert, James G. R. Wicker, Linda S. Rogers, Jane Harrow, Jennifer L. The non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetes |
title | The non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetes |
title_full | The non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetes |
title_fullStr | The non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetes |
title_full_unstemmed | The non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetes |
title_short | The non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetes |
title_sort | non-obese diabetic mouse sequence, annotation and variation resource: an aid for investigating type 1 diabetes |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668384/ https://www.ncbi.nlm.nih.gov/pubmed/23729657 http://dx.doi.org/10.1093/database/bat032 |
work_keys_str_mv | AT stewardcharlesa thenonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT gonzalezjosem thenonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT trevanionsteve thenonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT shepparddan thenonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT kerrygiselle thenonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT gilbertjamesgr thenonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT wickerlindas thenonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT rogersjane thenonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT harrowjenniferl thenonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT stewardcharlesa nonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT gonzalezjosem nonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT trevanionsteve nonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT shepparddan nonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT kerrygiselle nonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT gilbertjamesgr nonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT wickerlindas nonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT rogersjane nonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes AT harrowjenniferl nonobesediabeticmousesequenceannotationandvariationresourceanaidforinvestigatingtype1diabetes |